Fundraising FoxInozyme Pharma
Boston, US · Founded 2015 · Delaware corporation · 5 known investors
Find your way into Inozyme Pharma
Sign up to see every warm intro you have to Inozyme Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inozyme Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Inozyme Pharma was founded in 2015 by Axel Bolte.
Board
Investors · 5
How we know: Longitude Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Pivotal Life Sciences's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements$116.2M disclosed across 2 of 4 rounds · 2017–2018
- Undisclosed amountSeries ANov 2017Source ↗
▶$67.4MraisedJun 2020 · 12 investors · PharmaceuticalsRule 506(b)
- Sarah BhagatDirector
- Lynne SullivanDirector
- Reinaldo DiazDirector
- Rob HopfnerDirector
- Edward MathersDirector
- Martin EdwardsDirector
- Axel BolteExecutive Officer, Director
- Douglas TrecoDirector
- Offering amount
- $67.4M
- Amount sold
- $67.4M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$48.9MraisedNov 2018 · 14 investors · PharmaceuticalsRule 506(b)
- Axel BolteExecutive Officer, Director
- Edward MathersDirector
- Reinaldo DiazDirector
- Rob HopfnerDirector
- Martin EdwardsDirector
- Joseph SchlessingerExecutive Officer, Director
- Offering amount
- $48.9M
- Amount sold
- $48.9M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Inozyme Pharma went on to found or lead other companies.
Frequently asked questions
- Who founded Inozyme Pharma?
- Inozyme Pharma was founded by Axel Bolte in 2015.
- Who are Inozyme Pharma's investors?
- Inozyme Pharma's investors include Longitude Capital, New Enterprise Associates (NEA), Pivotal Life Sciences, Sanofi Ventures, Sofinnova Ventures.
- How much funding has Inozyme Pharma raised?
- Inozyme Pharma has disclosed $116.2M raised across 2 of its 4 known rounds.
- Where is Inozyme Pharma headquartered?
- Inozyme Pharma is headquartered in Boston, US.